메뉴 건너뛰기




Volumn 18, Issue 4, 2013, Pages

Breast cancer genomics: Challenges in interpretation and application

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; TAMOXIFEN;

EID: 84877065740     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2013-0116     Document Type: Note
Times cited : (1)

References (9)
  • 1
    • 71749091235 scopus 로고    scopus 로고
    • Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays
    • Albain KS, Paik S, van't Veer L. Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays. Breast 2009;18(suppl 3):S141-S145.
    • (2009) Breast , vol.18 , Issue.SUPPL. 3
    • Albain, K.S.1    Paik, S.2    Van'T, V.L.3
  • 2
    • 60849097255 scopus 로고    scopus 로고
    • Gene-expression signatures in breast cancer
    • Sotiriou C, Pusztai L. Gene-expression signatures in breast cancer. N Engl J Med 2009;360: 790-800.
    • (2009) N Engl J Med , vol.360 , pp. 790-800
    • Sotiriou, C.1    Pusztai, L.2
  • 3
    • 82355164800 scopus 로고    scopus 로고
    • The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor- positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialists
    • Joh JE, Esposito NN, Kiluk JV et al. The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor- positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialists. The Oncologist 2011;16: 1520-1526.
    • (2011) The Oncologist , vol.16 , pp. 1520-1526
    • Joh, J.E.1    Esposito, N.N.2    Kiluk, J.V.3
  • 4
    • 82355164826 scopus 로고    scopus 로고
    • Impact of multigene assays in early stage breast cancer
    • Lo SS, Albain KS. Impact of multigene assays in early stage breast cancer. The Oncologist 2011;16: 1482-1483.
    • (2011) The Oncologist , vol.16 , pp. 1482-1483
    • Lo, S.S.1    Albain, K.S.2
  • 5
    • 73249140371 scopus 로고    scopus 로고
    • Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with nodepositive, oestrogen-receptor-positive breast cancer on chemotherapy: A retrospective analysis of a randomised trial
    • Albain KS, Barlow WE, Shak S et al. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with nodepositive, oestrogen-receptor-positive breast cancer on chemotherapy: A retrospective analysis of a randomised trial. Lancet Oncol 2010;11:55-65.
    • (2010) Lancet Oncol , vol.11 , pp. 55-65
    • Albain, K.S.1    Barlow, W.E.2    Shak, S.3
  • 6
    • 78049453780 scopus 로고    scopus 로고
    • A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer
    • Nielsen TO, Parker JS, Leung S et al. A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer. Clin Cancer Res 2010;16:5222-5232.
    • (2010) Clin Cancer Res , vol.16 , pp. 5222-5232
    • Nielsen, T.O.1    Parker, J.S.2    Leung, S.3
  • 7
    • 84866544308 scopus 로고    scopus 로고
    • Molecular tumor characteristics influence adjuvant endocrine treatment outcome
    • Bianchini G, Pusztai L, Iwarnoto T et al. Molecular tumor characteristics influence adjuvant endocrine treatment outcome. Cancer Research 2011; 71(suppl 3):S1-S7.
    • (2011) Cancer Research , vol.71 , Issue.SUPPL. 3
    • Bianchini, G.1    Pusztai, L.2    Iwarnoto, T.3
  • 8
    • 77957935139 scopus 로고    scopus 로고
    • Genomic index of sensitivity to endocrine therapy for breast cancer
    • Symmans WF, Hatzis C, Sotiriou C et al. Genomic index of sensitivity to endocrine therapy for breast cancer. J Clin Oncol 2010;28:4111-4119.
    • (2010) J Clin Oncol , vol.28 , pp. 4111-4119
    • Symmans, W.F.1    Hatzis, C.2    Sotiriou, C.3
  • 9
    • 77951637777 scopus 로고    scopus 로고
    • Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: A TransATAC study
    • Dowsett M, Cuzick J, Wale C et al. Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study. J Clin Oncol 2010;28:1829-1834.
    • (2010) J Clin Oncol , vol.28 , pp. 1829-1834
    • Dowsett, M.1    Cuzick, J.2    Wale, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.